SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-049777
Filing Date
2021-12-27
Accepted
2021-12-27 16:42:32
Documents
1
Period of Report
2021-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3336
  Complete submission text file 0000899243-21-049777.txt   4858
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306
Business Address
Hwang Sooin (Reporting) CIK: 0001862522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39244 | Film No.: 211521056